James C. Yao
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States(2008)4,490 cited
- → Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States(2017)3,401 cited
- → Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors(2017)3,053 cited
- → Everolimus for Advanced Pancreatic Neuroendocrine Tumors(2011)2,831 cited
- → Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study(2015)1,241 cited
- → Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study(2011)1,046 cited